From CND to EMDN: the new classification system for medical devices

In the latest years, the sector of medical devices (MD) and in vitro diagnostics (IVD) underwent important regulatory and organisation changes at national and European level.
One of these changes concerns the introduction of a new classification system for MDs and IVDs, the EMDN (European Medical Device Nomenclature).
This is a European nomenclature that was developed starting from the CND nomenclature (National Classification of Medical Devices), created by Italy: in other words, the European Commission has decided to adopt the CND as a base for the development of the EMDN nomenclature.
The CND as a model
The CND was developed in Italy in 2007 with the goal of creating a hierarchical and systematic structure to classify all MDs and IVDs on the market, supporting administrative management and national expenditure. Its being organised in categories, groups and types has made possible a centralised and consistent management of information in the Italian “Repertorio dei Dispositivi Medici” (Medical Device Catalogue).
In time, the CND has attracted the attention of the European authorities for its completeness, flexibility and logic structure. When, with the entering into force of Regulation (EU) 2017/745 (MDR) and Regulation (UE) 2017/746 (IVDR), the European Union decided to introduce a mandatory common nomenclature for the registration of medical devices in EUDAMED (the European database), it was necessary to adopt or develop a European standard system.
Among the evaluated options (including the GMDN – Global Medical Device Nomenclature), the European Commission selected the CND as base for the development of the EMND, acknowledging its strong points:
- Public origin and transparent governance: the CND was developed and maintained by a public body (Italian Ministry of Health), ensuring market independence.
- Hierarchical structure and stable codification: the logical organisation of the CND makes it suitable for the integration into information systems and for interoperability.
- Consolidated adoption in the practice: the CND have been used for years in the Italian national health system to manage databases, procurement procedures, health expenditure control, and post-marketing surveillance.
The creation of the EMDN
Italy has therefore cooperated actively with the European Commission to adjust and harmonise the CND into a European version. In 2020, an extraordinary revision of the CND was carried out, and from this process the EMDN was born.
In 2019, following the agreement with the Medical Device Coordination Group (MDCG), the European Commission announced the adoption the Italian classification system CND, as base for the future European medical device nomenclature, the EMDN.
Following this decision, in the period 2018-2021 the Italian Ministry of Health with the support of the autonomous region Friuli Venezia Giulia has contributed to the release of the first version of the EMDN in Italian.
On 20 March 2023 the project SMEMDN – Supporting the maintenance of the European Medical Device Nomenclature was started, within the legal frame of the European Union, defining the operations required to support and maintain/update the European nomenclature of the medical devices based on the state of the art.
On 28 May 2025, at the headquarters of the Italian Ministry of Health, a training was held, “EMDN v.2, Focus on Updates and Nomenclature Use”. In fact, this is a significant change requiring updates in the managing software, purchase procedures staff training.
The EMDN maintains the tree structure and classifying principle of the CND, although introducing changes and updates to adapt to the European contexts and to the new technologies. Compared to the CND, the EMDN provides a more detailed and structured approach, able to represent more specifically the technical and functional characteristics of medical devices. This allows competent authorities, economic operators, and health professionals a better data management, with a positive impact on safety, innovation and transparency.
The Classification presents a tree alphanumeric structure, that is hierarchical and multilevel (with a maximum of 7 levels) grouping devices in three main levels:
- Categories identified by an alphabet letter represent the 1st level of structure
- Groups identified with a numeric couple represent the 2nd level of structure
- Types identified with further series of number couples that can reach different levels of detail (1 to 5) for each Group.

Each level is defined by an alphanumeric code (as described above) and by a short descriptive text (description) summarising the device characteristics the level is dedicated to. The level of maximum detail allowed is 13 digits.
By increasing the granularity of the detail levels (1 to 7), the devices are grouped based on characteristics that are increasingly similar.
This organisation makes the nomenclature stable in time up to level 3 (Category, Group, Type 1) and, for some Categories, even for more detailed levels.
Each level can be updated, when needed, ensuring stability and homogeneity of development and allowing representativity of the various device sectors.
What’s new in the new codes
The EMDN reflects some novelties introduced by the Regulations. One of these concerns the field of application of the MDR to devices with no medical purposes (Annex XVI).
In order to be able to assign an EMDN code also to these products, and comply with the requirements for the registration into EUDAMED, an additional category was added to those of the CND. This is category 23, to which the letter X was attributed.
There was therefore an increase in the codes, showing such huge work. It is not a final number, as the system is open, and has to adapt to the context and technologies.
The intended use of DMs/IVDs is an essential element in the attribution of the EMDN code by manufacturers. NBs may request the rationale that led to the selection of a specific EMDN code, therefore it is not only required for the EUDAMED registration, but is an important tool also for the monitoring of several activities, such as post-market surveillance, vigilance and health expenditure.
The switch from the CND to the EMDN is an example of how the European regulatory framework is leading the innovation and harmonisation in the health sector. Although such transition involves operative challenges, the expected benefits in terms of efficiency, safety and transparency are relevant, consolidating the role of Italy in the European market of medical devices.
Previous Post
Next Post